Why? So another management group can continue the trials and any other preparation at Muchea, incurring the same if not more cost (factoring in options and equity dilution) than current management?Agreed. Me either. But surely there isn't significant cost left. Unless updating the rts requires some insane amount of work by the environmental consultant??
- Forums
- ASX - By Stock
- VRX
- Ann: Entitlement Issue Prospectus
Ann: Entitlement Issue Prospectus, page-58
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VRX (ASX) to my watchlist
|
|||||
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.47M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 185 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 16290 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 185 | 0.032 |
4 | 340000 | 0.030 |
2 | 200000 | 0.029 |
1 | 100000 | 0.028 |
2 | 160000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 16290 | 1 |
0.036 | 286529 | 1 |
0.037 | 76412 | 1 |
0.038 | 14000 | 1 |
0.039 | 186660 | 1 |
Last trade - 16.12pm 13/08/2024 (20 minute delay) ? |
Featured News
VRX (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online